Jaundice
Jaundice is a common symptom and sign. It occurs due to the increase in serum bilirubin concentration caused by bilirubin metabolism disorder. Clinically, the sclera, mucous membranes, skin and other tissues are stained yellow. Because the sclera contains more elastin, which has a strong affinity with bilirubin, the yellow staining of the sclera of jaundice patients is often first noticed before the mucous membranes and skin. When the total serum bilirubin is between 17.1 and 34.2 μmol/L, and jaundice is not visible to the naked eye, it is called latent jaundice or subclinical jaundice; when the total bilirubin concentration in the blood exceeds 34.2 μmol/L, jaundice can be found clinically, which is also called overt jaundice.
Related Drugs
Gantai Granules
Manufacturer:
Tai Chi Group Sichuan Mianyang Pharmaceutical Co., Ltd.
Yinzhihuang Granules
Indication: Clears away heat and detoxifies, removes dampness and relieves jaundice. It has the effect of relieving jaundice and lowering alanine aminotransferase. It is used for acute and chronic hepatitis and severe hepatitis (type I) caused by internal damp-heat toxicity. It can also be used for the comprehensive treatment of other types of severe hepatitis.
Manufacturer:
Lunan HOPE Pharmaceutical Co., Ltd.
Artemisinin
Indication: It is mainly used for symptom control of Plasmodium vivax malaria and Plasmodium falciparum malaria, and for the treatment of chloroquine-resistant strains. It can also be used to treat severe Plasmodium falciparum malaria, such as cerebral and icteric malaria. It can also be used to treat systemic lupus erythematosus and discoid lupus erythematosus.
Artemisinin
Indication: It is mainly used for symptom control of Plasmodium vivax malaria and Plasmodium falciparum malaria, and for the treatment of chloroquine-resistant strains. It can also be used to treat severe Plasmodium falciparum malaria, such as cerebral and icteric malaria. It can also be used to treat systemic lupus erythematosus and discoid lupus erythematosus.
Manufacturer:
Chuxiong Yunzhi Phytopharmaceutical Co., Ltd.
Artemisinin
Indication: It is mainly used for symptom control of Plasmodium vivax malaria and Plasmodium falciparum malaria, and for the treatment of chloroquine-resistant strains. It can also be used to treat severe Plasmodium falciparum malaria, such as cerebral and icteric malaria. It can also be used to treat systemic lupus erythematosus and discoid lupus erythematosus.
Manufacturer:
China Resources 39 (Youyang) Pharmaceutical Co., Ltd.
Artemisinin
Indication: It is mainly used for symptom control of Plasmodium vivax malaria and Plasmodium falciparum malaria, and for the treatment of chloroquine-resistant strains. It can also be used to treat severe Plasmodium falciparum malaria, such as cerebral and icteric malaria. It can also be used to treat systemic lupus erythematosus and discoid lupus erythematosus.